From April 21 – 23, 2022, I was honored to attend the 3rd
VIPOC (Vitiligo International Patient Organizations Conference)
in Amsterdam, Netherlands.
I’d like to begin with a round of applause for VSI members! On 2/12/21, VSI sent out an email announcement about the (then) upcoming FDA “Patient-Focused Drug Development Meeting for Vitiligo,” and boy did you guys ever come through! By Saturday morning, my inbox was filled with messages from those of you trying to register for the event only to be notified that the event was sold out. On Monday morning, I contacted the meeting director about the situation and they had registration reopened within 24 hours!
Each year as I compose my year-end message, I reflect on the year’s developments, events, news, etc., in a vitiligo “state-of-the-year” sort of way. While the work of research, advocacy, and awareness in the world of vitiligo most definitely continued this year, it may have seemed, like so much else in the world, to be lost in the background.
It seems like a lifetime has passed since the message I wrote for the Spring newsletter when COVID-19 was beginning its epic spread. I don’t think many of us could have imagined the turmoil the world would be facing in the months that have followed. We’d never even heard of terms such as “social distancing.”